454 related articles for article (PubMed ID: 17467549)
21. Cystic fibrosis newborn screening.
Com G
J Ark Med Soc; 2010 Mar; 106(9):210-2. PubMed ID: 20337169
[TBL] [Abstract][Full Text] [Related]
22. Variation in immunoreactive trypsinogen concentrations among Michigan newborns and implications for cystic fibrosis newborn screening.
Korzeniewski SJ; Young WI; Hawkins HC; Cavanagh K; Nasr SZ; Langbo C; Teneyck KR; Grosse SD; Kleyn M; Grigorescu V
Pediatr Pulmonol; 2011 Feb; 46(2):125-30. PubMed ID: 20848586
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of newborn screening for cystic fibrosis determined with real-life data.
van der Ploeg CP; van den Akker-van Marle ME; Vernooij-van Langen AM; Elvers LH; Gille JJ; Verkerk PH; Dankert-Roelse JE;
J Cyst Fibros; 2015 Mar; 14(2):194-202. PubMed ID: 25213034
[TBL] [Abstract][Full Text] [Related]
24. A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis.
Mayell SJ; Munck A; Craig JV; Sermet I; Brownlee KG; Schwarz MJ; Castellani C; Southern KW;
J Cyst Fibros; 2009 Jan; 8(1):71-8. PubMed ID: 18957277
[TBL] [Abstract][Full Text] [Related]
25. [The French nationwide cystic fibrosis newborn screening program: strategy and results].
Munck A; Roussey M
Arch Pediatr; 2008 Jun; 15 Suppl 1():S1-6. PubMed ID: 18822253
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis of cystic fibrosis after newborn screening: the Australasian experience--twenty years and five million babies later: a consensus statement from the Australasian Paediatric Respiratory Group.
Massie J; Clements B;
Pediatr Pulmonol; 2005 May; 39(5):440-6. PubMed ID: 15704202
[TBL] [Abstract][Full Text] [Related]
27. Newborn screening and carrier screening for cystic fibrosis: alternative or complementary?
Castellani C; Massie J
Eur Respir J; 2014 Jan; 43(1):20-3. PubMed ID: 24381320
[No Abstract] [Full Text] [Related]
28. Neonatal screening for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis: four years' experience.
Ranieri E; Lewis BD; Gerace RL; Ryall RG; Morris CP; Nelson PV; Carey WF; Robertson EF
BMJ; 1994 Jun; 308(6942):1469-72. PubMed ID: 8019280
[TBL] [Abstract][Full Text] [Related]
29. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis.
Massie J; Forbes R; Dusart D; Bankier A; Delatycki MB
J Paediatr Child Health; 2007 Nov; 43(11):721-3. PubMed ID: 17924936
[TBL] [Abstract][Full Text] [Related]
30. Newborn screening for cystic fibrosis.
Wagener JS; Zemanick ET; Sontag MK
Curr Opin Pediatr; 2012 Jun; 24(3):329-35. PubMed ID: 22491493
[TBL] [Abstract][Full Text] [Related]
31. Comparison of different IRT-PAP protocols to screen newborns for cystic fibrosis in three central European populations.
Sommerburg O; Krulisova V; Hammermann J; Lindner M; Stahl M; Muckenthaler M; Kohlmueller D; Happich M; Kulozik AE; Votava F; Balascakova M; Skalicka V; Stopsack M; Gahr M; Macek M; Mall MA; Hoffmann GF
J Cyst Fibros; 2014 Jan; 13(1):15-23. PubMed ID: 23891278
[TBL] [Abstract][Full Text] [Related]
32. Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening.
Koscik RL; Lai HJ; Laxova A; Zaremba KM; Kosorok MR; Douglas JA; Rock MJ; Splaingard ML; Farrell PM
J Pediatr; 2005 Sep; 147(3 Suppl):S51-6. PubMed ID: 16202783
[TBL] [Abstract][Full Text] [Related]
33. Implementation of informed consent for a cystic fibrosis newborn screening program in France: low refusal rates for optional testing.
Dhondt JL
J Pediatr; 2005 Sep; 147(3 Suppl):S106-8. PubMed ID: 16202772
[TBL] [Abstract][Full Text] [Related]
34. Novel strategies in newborn screening for cystic fibrosis: a prospective controlled study.
Vernooij-van Langen AM; Loeber JG; Elvers B; Triepels RH; Gille JJ; Van der Ploeg CP; Reijntjens S; Dompeling E; Dankert-Roelse JE;
Thorax; 2012 Apr; 67(4):289-95. PubMed ID: 22271776
[TBL] [Abstract][Full Text] [Related]
35. Assessing the cost of cystic fibrosis diagnosis and treatment.
Rosenberg MA; Farrell PM
J Pediatr; 2005 Sep; 147(3 Suppl):S101-5. PubMed ID: 16202771
[TBL] [Abstract][Full Text] [Related]
36. Cystic fibrosis: refining the approach to newborn screening.
Wilcken B
J Pediatr; 2009 Nov; 155(5):605-6. PubMed ID: 19840611
[No Abstract] [Full Text] [Related]
37. Parental understanding of newborn screening for cystic fibrosis after a negative sweat-test.
Lang CW; McColley SA; Lester LA; Ross LF
Pediatrics; 2011 Feb; 127(2):276-83. PubMed ID: 21220393
[TBL] [Abstract][Full Text] [Related]
38. Policy issues for expanding newborn screening programs: the cystic fibrosis newborn screening experience in the United States.
Wilfond BS; Gollust SE
J Pediatr; 2005 May; 146(5):668-74. PubMed ID: 15870672
[TBL] [Abstract][Full Text] [Related]
39. Extended gene analysis can increase specificity of neonatal screening for cystic fibrosis.
Mérelle ME; Scheffer H; De Jong D; Dankert-Roelse JE
Acta Paediatr; 2006 Nov; 95(11):1424-8. PubMed ID: 17062471
[TBL] [Abstract][Full Text] [Related]
40. Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe.
Dankert-Roelse JE; Mérelle ME
J Pediatr; 2005 Sep; 147(3 Suppl):S15-20. PubMed ID: 16202775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
